11 completed, 1 not yet recruiting, 1 recruiting. 5 Phase 3, 4 Not applicable, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Not applicable | 4 | Completed 3, Recruiting 1 |
| Phase 2 | 3 | Completed 3 |
Follow Migraine With or Without Aura: new trials by email Literature Review of Migraine With or Without Aura trials Research Report on Migraine With or Without Aura
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea Rimegepant sulfate - Migraine With or Without Aura | Not yet recruiting | Pfizer | 3000 | 2027-03-01 | 2026-09-25 | |
| New Methods for Evaluating Preventive Migraine Treatment Active drug for chronic migraine treatment., Placebo Subcutaneous injection - Migraine, Migraine With or Without Aura | Not applicable | Recruiting | University of Aarhus | 60 | 2025-06-19 | 2026-05-19 |
| Evaluation of a Wearable Device for Acute Treatment of Migraines Transcutaneous Electrical Nerve Stimulation (TENS) - Migraine, Migraine With or Without Aura | Not applicable | Completed | Hinge Health, Inc | 160 | 2025-06-09 | 2025-10-30 |
| Cooling to Alleviate Migraine #3 Mi-Helper - Migraine With or Without Aura, Migraine | Not applicable | Completed | Mi-Helper, Inc. | 156 | 2025-03-24 | 2026-02-10 |
| Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency, Intensity, and Functionality: A Single-Arm Study Meditation - Migraine, Migraine With or Without Aura | Not applicable | Completed | Maharishi International University | 30 | 2024-08-28 | 2026-07-16 |
| The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination Low-Dose Naltrexone and Acetaminophen Combination, Placebo - Migraine With or Without Aura | Phase 2 | Completed | Allodynic Therapeutics, Inc | 12 | 2017-08-25 | 2024-04-10 |
| An Acute Migraine Factorial Study Naltrexone and Acetaminophen, Naltrexone and Acetaminophen-High Dose, Naltrexone Alone (regular dose) - Migraine With or Without Aura | Phase 2 | Completed | Allodynic Therapeutics, Inc | 92 | 2017-02-18 | 2024-02-07 |
| Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine Naltrexone and Acetaminophen, Naltrexone and Acetaminophen-High Dose, Naltrexone Alone (regular dose) - Migraine With or Without Aura | Phase 2 | Completed | Allodynic Therapeutics, Inc | 92 | 2017-02-18 | 2021-04-14 |
| Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine Lasmiditan 50 mg, Lasmiditan 100 mg, Lasmiditan 200 mg - Migraine With or Without Aura | Phase 3 | Completed | Eli Lilly and Company | 3005 | 2016-05-01 | 2019-09-23 |
| Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan Placebo, Eletriptan 40 mg, Eletriptan 80 mg - Migraine With or Without Aura | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 446 | 1999-01-01 | 2021-01-27 |
| Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo Placebo, Eletriptan 40 mg, Eletriptan 80 mg - Migraine With or Without Aura | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1141 | 1996-12-01 | 2021-01-28 |
| Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study Placebo, Eletriptan 40 mg, Eletriptan 80 mg - Migraine With or Without Aura | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1008 | 1996-11-01 | 2021-01-28 |
| Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine Placebo, Eletriptan 20 mg, Eletriptan 40 mg - Migraine With or Without Aura | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1334 | 1996-07-01 | 2021-01-28 |
Migraine Disorders (7) · Headache (3) · Headache Disorders (2) · Chronic Pain (1) · Migraine with Aura (1) · Migraine without Aura (1) · Pain (1)
Brain Diseases (7) · Central Nervous System Diseases (7) · Headache Disorders, Primary (7) · Nervous System Diseases (7) · Headache Disorders (5) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Pain (2)
eletriptan (4) · Naltrexone (3) · Acetaminophen (2) · Sumatriptan (2) · Meditation (1) · Transcutaneous Electric Nerve Stimulation (1) · lasmiditan (1) · rimegepant sulfate (1)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (4) · Allodynic Therapeutics, Inc (3) · Eli Lilly and Company (1) · Hinge Health, Inc (1) · Maharishi International University (1) · Mi-Helper, Inc. (1) · Pfizer (1) · University of Aarhus (1)
United States (7) · Denmark (2) · Finland (1) · Netherlands (1) · Norway (1) · Sweden (1)
Annette C Toledano, M.D. (2) · Annette Toledano, M.D. (1) · Dr. Fred T Travis, PhD (1) · Jessica Ailani, MD (1) · Lene Vase, MSc, PhD, DMSc (1) · Mallika Bariya, PhD (1)
PMID 11112243, PMID 16135345, PMID 17175134, PMID 18662331, PMID 19453963, PMID 20548058, PMID 22520687, PMID 25744676, PMID 26603732, PMID 28322750, PMID 29310498, PMID 31152441, PMID 31166697, PMID 31266353, PMID 31340760, PMID 31409292, PMID 31464581, PMID 31529622, PMID 31744319, PMID 32447545, PMID 32783644, PMID 33730977, PMID 33784930, PMID 34366152, PMID 34454420, PMID 34644189, PMID 35350937, PMID 35471625, PMID 35779194, PMID 36125279
2015 (1)